203 filings
Page 7 of 11
8-K
865 ujiqva
25 Mar 20
Evofem Biosciences Adopts Shareholder Rights Agreement
5:00pm
8-K
hy1rfr r1488nlt9
12 Mar 20
Evofem Biosciences Reports Fourth Quarter and Year-end 2019
8:00am
8-K
7ks19r
26 Feb 20
Evofem Biosciences Appoints Former FDA Division Director Lisa Rarick, M.D., to its Board of Directors
8:30am
8-K
wq6kdoyy ago
10 Jan 20
Regulation FD Disclosure
4:06pm
8-K
a5q2a82 xo3dnrcueh
16 Dec 19
Departure of Directors or Certain Officers
4:35pm
8-K
sssb0yusu10
2 Dec 19
Other Events
6:50am
8-K
tou0spp tf7r
26 Nov 19
Other Events
7:30am
8-K
icnfj2t5 kwnzrrsq7i
6 Nov 19
Evofem Biosciences Reports Third Quarter 2019
4:06pm
8-K
asz1pjjig5ge3m
11 Oct 19
Entry into a Material Definitive Agreement
4:29pm
8-K
ckejmqp9 7xzw3oyv
4 Sep 19
Regulation FD Disclosure
9:07am
8-K
8yt64ctf6e44
5 Aug 19
Evofem Biosciences Reports Second Quarter 2019
4:11pm
8-K
r61exv6sb25 uf
10 Jun 19
Evofem Biosciences Closes $80 Million Financing Transaction
4:01pm
8-K
dpshy2cfg9
5 Jun 19
Departure of Directors or Certain Officers
5:07pm
8-K
ch3aoj 4d
7 May 19
Evofem Biosciences Reports First Quarter 2019
6:13am
8-K
62epzk
11 Apr 19
Closes First Tranche of Strategic Investment from PDL BioPharma
5:16pm
8-K
wvxp1l9gz3 z83
1 Mar 19
Evofem Biosciences Reports Fourth Quarter and Year-End 2018
12:00am
8-K
mgus bflm
11 Feb 19
Entry into a Material Definitive Agreement
4:12pm
8-K
ydfkou5pmyl
7 Jan 19
Regulation FD Disclosure
6:11am
8-K
yzzxleb230dtd13y
3 Jan 19
Evofem Biosciences Provides Corporate Update and Announces Upcoming Milestones
8:00am
8-K
hdhyi
17 Dec 18
Evofem Biosciences Announces Positive Top-Line Results of Phase 3 Study
6:05am